11種類の腫瘍における癌の移行時の表遺伝子調節
Nadezhda V Terekhanova1,2, Alla Karpova1,2, Wen-Wei Liang1,2
1Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
Nature
|November 2, 2023
まとめ
この研究は100万以上の細胞を分析することで 癌の発症と転移の主要な表遺伝的要因を明らかにしました この発見は,癌の進行における表遺伝的変化,遺伝子発現,遺伝的要因の相互作用を強調しています.
科学分野:
- ゲノミクス
- エピジェネティクス
- 癌 生物学
背景:
- クロマチンのアクセシビリティは 遺伝子発現と細胞のアイデンティティを制御し 癌を理解する上で極めて重要です
- クロマチンのアクセシビリティの変化は,がんの発症,進行,転移に関与しています.
- 腫瘍性変異のエピジェネティックな要因は 遺伝的要因と比較して 解明されていない.
研究 の 目的:
- パン癌のエピジェネティックとトランスクリプトミックのアトラスを構築する.
- 単核クロマチンのアクセシビリティとRNAシーケンシングデータを用いて,癌の移行に関連したエピジェネティック・ドライバーを特定する.
- 強化剤のアクセシビリティと遺伝子発現の相関性を調査し,エピジェネティックと遺伝的誘導因子の協力関係を明らかにする.
主な方法:
- 225個のがんサンプルでトランポゼーゼアクセシブルクロマチン (snATAC-seq) の単核測定法を使用した.
- 206個のサンプルから得られた単細胞または単核RNAシーケンシング (sc/snRNA-seq) データと統合されたsnATAC-seqデータ.
- 100万以上の細胞を分析し,アクセス可能なクロマチン領域,転写因子モチーフ,レギュロンなどを特定した.
主要な成果:
- 一般的およびがん特異的な表遺伝因子 (例えば,ABCC1,VEGFA,GATA6,FOXファミリーモチーフ,FGF19,ASAP2,EN1,PBX3モチーフ) を特定した.
- TP53,低酸素,TNF信号などの特定の経路が癌の発症と関連しています.
- 関連するエストロゲン反応,上皮-メゼンキーマ移行,および転移経路の頂点結節.
- 強化剤のアクセシビリティと遺伝子発現の強い相関関係と,表遺伝的および遺伝的要因の協力関係を明らかにした.
結論:
- 構築されたアトラスは,がんにおける表遺伝子動態の調査のための基盤を提供します.
- エピジェネティック・ドライバは癌の発症,進行,転移において重要な役割を果たします.
- エピジェネティックと遺伝的要因の相互作用を理解することは 癌の研究にとって極めて重要です
さらに関連する動画
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
775
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.6K
関連する概念動画
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
